Foley Partners Jeff Greene and Andy Baum are scheduled to speak on IP Defense and Brand Protection at ALM’s 20th Annual General Counsel Conference, June 9 – 10, 2008 in New York, New York.
Their panel will discuss the following topics:
-
Protecting your intellectual property goes hand-in-hand with protecting your brand
-
Globalize marketplace
-
Aggressive defense can mean trouble in the court of public opinion, especially if a large company is perceived as bullying.
-
How can companies effectively protect their intellectual property—and their reputations—in a global environment?
In addition Foley will be sponsoring the Networking Reception that will be held on June 9th at 5:30 p.m.
For more information on this event, please visit www.almevents.com/gceast.
People
Related Insights
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.
23 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About…Tariff Strategies for Sell-Side Contracts
With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.